All research papers

Radiopharmaceuticals for Melanoma Theranostics.

Influence of forehead gap size on eye protection provided by lead eyewear worn over prescription glasses: A Monte Carlo study.

Automated offline adaptive radiotherapy through CBCT imaging: A multidimensional feasibility study of hypersight and iterative CBCT.

A simple and interpretable method to predict head and neck offline adaptation needs based on anatomical changes.

DoseRAD2026: A benchmark dataset for AI-accelerated photon and proton dose calculation in radiotherapy.

Stereotactic body radiation therapy for pancreatic cancer: evaluating its efficacy, safety, and future prospects: systematic review.

Real-time intrafraction 3D spine tracking using gantry-mounted kV imaging for single fraction high dose functional radiosurgery.

Deep learning for gamma map prediction in breast IMRT verification.

Optimizing TrueBeam jaw calibrations to reduce positional errors at customizable gantry and collimator angles.

Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT in gastric cancer: impact on metastatic detection and stage migration.

Single-time-point renal dosimetry for [¹⁷⁷Lu]Lu-PSMA-617: Incorporating multi-cycle population data using nonlinear mixed-effects models.

Geometric and dosimetric effects of an automated clustering and plan optimization pipeline for multiple brain metastasis radiosurgery.

The Impact of Nodular Goiter on the Short-Term Efficacy of Radioactive Iodine Therapy for Differentiated Thyroid Carcinoma: A Propensity Score Matching Study.

Exploring Geiger Count Thresholds for Sentinel Node Identification in Melanoma: Is 10 % Still Optimal?

Online adaptive radiotherapy for prostate cancer: Current evidence and clinical perspectives.

Stereotactic body radiotherapy for oligometastatic ovarian cancer: Current evidence, patient selection, and future directions.

Practical considerations of gadoxetate disodium contrast in MRI-guided liver SBRT for primary and secondary liver tumors: optimizing image quality and patient throughput.

Radiopharmaceuticals and theranostics: reshaping cancer diagnosis and therapy with targeted radionuclides.

Real-World Safety and Effectiveness of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer: Final Analysis of the RAPIT Study.

Evaluation of Concordance between Radiation Therapists and Medical Physicists in MR-Guided Online Adaptive Planning.

Normal variants, pitfalls, and interpretation challenges of somatostatin receptor PET.

Perioperative chemotherapy and stereotactic body radiotherapy versus perioperative chemotherapy alone in patients with high-risk, localised pancreatic cancer (MASTERPLAN): an open-label, phase 2, multicentre, randomised trial of the Australasian Gastro-Intestinal Trials Group.

Association of planned-recorded sinogram difference metrics with treatment planning parameters and gamma pass rates in helical tomotherapy.

Effect of data-driven gating on the quantification of prostate cancer metastases in ⁶⁸Ga-PSMA- and ¹⁸F-DCFPyL-PSMA PET/CT.

Unusual Gastric Metastases in the Setting of Recurrence of Pancreatic NET: Dual Tracer PET/CT and Theranostic Approach.

A Study of Radiation Exposure and the Effects of Real-Time Dosimetry System on Staff Safety in Neurointerventional Procedures.

Dynamic Sentinel Lymph Node Biopsy (DSNB) in Penile Cancer: A Practical Guide for Clinical Implementation.

Trends in multi-lesion stereotactic radiosurgery: an IROC survey on the state of the practice.

In silico assessment of out-of-field dose in multiple brain metastases stereotactic radiosurgery.

A Phase 1 Trial Investigating the Addition of Papaverine to Stereotactic Body Radiotherapy (SBRT) for Hypoxic Radiosensitization of Lung Tumors.

Streamlining Liver SABR: Validation and Initial Experience of Bulk Density Override Based Single-Session, Simulation-Free Adaptive Workflow.

From contouring variability to dosimetric impact: a comprehensive assessment of online adaptive MR-guided SBRT for pancreatic cancer.

Radiobiological dosimetry using hybrid imaging-derived spatiotemporal dose distributions for¹³¹I therapy of metastatic thyroid cancer.

Sequential Therapy with Anlotinib and Radioiodine for Distant Metastatic Differentiated Thyroid Cancer: A Phase II Clinical Trial.

Quality assurance planning for Actinium-225: Layering current good manufacturing practice requirements onto US department of energy/nuclear safety quality systems to support medical isotope production suitable for clinical trial use.

Asymptomatic Appendiceal Metastasis From Prostate Cancer Mimicking Metastatic Lymph Node as Solitary Disease on PSMA PET/CT Scan: The First Reported Case of Presurgical Diagnosis and Review of Literature.

Clinical Value of [⁶⁸Ga]Ga-FAPI-46 PET/CT Versus [¹⁸F]FDG PET/CT for Primary Staging of Gastroesophageal Adenocarcinoma: Results from a Prospective Northern European Trial.

Comparison of 99mTc-Phytate and 99mTc-Antimony Trisulfide in sentinel lymph node detection: a lymphoscintigraphy study in breast cancer patients.

A liquid fiducial marker for image-guided proton beam therapy of abdominal tumors.

CBCT-guided plan-of-the-day adaptive radiotherapy for locally advanced cervical cancer: Feasibility and dosimetric evaluation in a resource-limited setting.

Advances in Stereotactic Body Radiation Therapy: Expanding Clinical Applications and Improving Treatment Precision.

Incidental Popliteal Bursa Localization on I-131 Whole-Body Scintigraphy.

Impact of reduced scan extent on tumor detection in ⁶⁸Ga-PSMA PET/CT for biochemical recurrence of prostate cancer.

From blue dye to multimodal-guided surgery: The evolution of sentinel lymph node mapping in vulvar cancer - A narrative review.

CBCT-Guided Online Adaptive Ultrahypofractionated Whole-Breast Radiotherapy for Early-Stage Breast Cancer: Dosimetric Outcomes and Acute Toxicity.

Thyroid Differentiation Score as a Molecular Bridge Between Genotype, Tumor Biology, and Radioiodine Theranostics in Thyroid Cancer.

A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-FDG, 68Ga-DOTATATE, and 18F-MFBG in a Pediatric Neuroblastoma Patient.

Not Every PSMA-Expressing Bone Lesion Is Prostate Cancer: Incidental Detection of Metastatic Differentiated Thyroid Carcinoma on Staging 68Ga-PSMA-11 PET/CT.

[18F]AlF-NOTA-FAPI-04 PET/CT for Incidental Detection of a Benign Phyllodes Tumor in a Patient With Prior Colon Cancer.

FAPI PET/CT Outperforms MRI and FDG PET/CT in Tumor Delineation for Low-grade Nasopharyngeal Papillary Adenocarcinoma.

99mTc-FAPI-46 SPECT/CT in Ewing Sarcoma: Findings in Diverse Metastatic Presentations.

Five-Year Persistent 18F-FAPI-74 Uptake in Radiation-induced Hepatic Fibrosis Following Proton Beam Therapy for Hepatocellular Carcinoma.

A Head-to-Head Comparison of Detection Rate and Tumor Uptake of FAPI, PSMA, and FDG PET/CT in Newly Diagnosed High-risk Prostate Cancer.

Vertebral Hemangioma Sparing in a 99mTc-PSMA Superscan.

Multimodal Evaluation of [²²⁵Ac]Ac-PSMA-617 Therapy in mCRPC: PET Based Total Tumor Volume, PSA Kinetics, and Blood Biomarkers.

Performance of⁶⁸Ga-PSMA-11 PET/CT for Diagnosing Tumor Thrombus and Predicting Response to Pembrolizumab and Axitinib in Patients with Renal Cell Carcinoma: A Pilot, Retrospective Study.

Survival outcomes with Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer patient according to baseline tumor characteristics.

ExacTrac Dynamic Surface-Guided Setup Versus Tattoo-Based Positioning in Breast Cancer Radiotherapy: A Retrospective Comparison of Setup Accuracy and Preparation Time.

Assessing the impact of knowledge-based planning on dosimetric performance in adaptive prostate stereotactic body radiation therapy.

Iodine-131 S-values of post-thyroidectomy adult Filipino mesh-type computational phantoms.